13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC
ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 21 holding rows worth $412,723,000.
- Accession
- 0001085146-18-001524
- Filer
- CIK 1012622
- Filed
- 2018-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, 21 entries on the cover page, a total value of $412,723,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $412,723,000 with VALUE read as thousands by filing date, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| QUIDEL CORP | 74838J101 | COM | 2,336,448 | $121,051,000 | thousands by filing date | |
| ACCELR8 TECHNOLOGY INC | 004304200 | COM | 4,447,618 | $101,628,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 844,718 | $48,267,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 9,537,661 | $19,552,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 5,176,479 | $15,581,000 | thousands by filing date | |
| MAZOR ROBOTICS LTD | 57886P103 | SPONSORED ADS | 246,317 | $15,114,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 1,330,070 | $14,937,000 | thousands by filing date | |
| VERMILLION INC | 92407M206 | COM NEW | 9,825,289 | $13,362,000 | thousands by filing date | |
| BIOLASE INC | 090911108 | COMMON STOCK | 30,866,262 | $12,532,000 | thousands by filing date | |
| OPKO HEALTH INC | 68375N103 | COM | 3,686,194 | $11,685,000 | thousands by filing date | |
| AGENUS INC | 00847G101 | COM | 1,547,392 | $7,288,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 396,325 | $7,035,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 174,525 | $6,894,000 | thousands by filing date | |
| CONTRAFECT CORP | 212326102 | COM | 3,167,013 | $5,147,000 | thousands by filing date | |
| SOLENO THERAPEUTIVS, INC. | 834203200 | COMM | 2,388,060 | $4,330,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 238,478 | $2,218,000 | thousands by filing date | |
| QUIDEL CORP | 74838J101 | COM | 198,300 | $2,151,000 | thousands by filing date | call |
| BIOGEN INC COM | 09062X103 | Stock | 6,368 | $1,744,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 776,900 | $1,199,000 | thousands by filing date | call |
| ACCELR8 TECHNOLOGY INC | 004304200 | COM | 516,400 | $910,000 | thousands by filing date | call |
| SECOND SIGHT MED PRODS INC | 81362J100 | COM | 50,804 | $98,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-18-001524 | this filing | 2018-05-15 | acceptance time not in the bulk data set |